Status:
COMPLETED
Validation of a Shared Decision-Making Tool for Multiple Sclerosis
Lead Sponsor:
Shared Decision Making Resources
Collaborating Sponsors:
EMD Serono
Multiple Sclerosis Association of America
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study evaluates a novel shared decision making tool for multiple sclerosis (MS). Half the patients will be given access to MS-SUPPORT before their scheduled appointment with their healthcare prov...
Detailed Description
MS-SUPPORT is a novel shared-decision making tool. More specifically, it is a web-based decision aid (DA) that includes 'values clarification exercises' to support people with MS (PwMS) incorporate th...
Eligibility Criteria
Inclusion
- For MS patients:
- Inclusion criteria:
- Able to read and write in English
- Live within the United States and receive MS care in the USA
- 18 years or older
- Having a diagnosis of a relapsing form of MS, including Relapsing Remitting Multiple Sclerosis (RRMS), active secondary progressive MS, and Clinically Isolated Syndrome (CIS)
- Having access to the internet
- Having a valid email address
- Have a healthcare provider who is managing their MS
- Having an upcoming appointment with an MS healthcare provider to manage their MS within the next 12 weeks
- Exclusion criteria:
- • Unable or unwilling to give informed consent
- For HCPs:
- Inclusion criteria:
- English-speaking
- Any HCP who manages a participating patient's MS
- Exclusion criteria:
- • Unable or unwilling to give informed consent
Exclusion
Key Trial Info
Start Date :
November 12 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 23 2021
Estimated Enrollment :
501 Patients enrolled
Trial Details
Trial ID
NCT04122989
Start Date
November 12 2019
End Date
December 23 2021
Last Update
May 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shared Decision Making Resources
Georgetown, Maine, United States, 04548